Literature DB >> 19124632

Women at high risk for breast cancer--what the primary care provider needs to know.

Nelia Afonso1.   

Abstract

Until recently, the assessment made by the primary care provider regarding screening for breast cancer was generally limited to decisions about when to initiate mammography. Early diagnosis was stressed as the best protection against breast cancer morbidity. However, there have been recent developments in the ability to predict and modify breast cancer risk. It is therefore important for the primary care provider to be able to identify women at higher risk for breast cancer and be familiar with issues regarding screening and risk reduction. Recent data regarding the evaluation of breast cancer risk, newer screening strategies for high-risk women, and medical and surgical approaches to reduce breast cancer risk and are discussed in this article.

Entities:  

Mesh:

Year:  2009        PMID: 19124632     DOI: 10.3122/jabfm.2009.01.070188

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  7 in total

1.  Facilitators and Challenges in Psychosocial Adaptation to Being at Increased Familial Risk of Breast Cancer.

Authors:  Louise Heiniger; Melanie A Price; Margaret Charles; Phyllis N Butow
Journal:  J Genet Couns       Date:  2015-03-05       Impact factor: 2.537

2.  Lack of association of genetic polymorphisms of angiotensin converting enzyme 1 and angiotensin II type 1 receptor with breast cancer risk in Iranian population.

Authors:  Soha Namazi; Ahmad Monabati; Shirin Ardeshir-Rouhani-Fard; Negar Azarpira
Journal:  Tumour Biol       Date:  2013-05-23

3.  Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study.

Authors:  Sharareh Taghipour; Dragan Banjevic; Joanne Fernandes; Anthony B Miller; Neil Montgomery; Andrew K S Jardine; Bart J Harvey
Journal:  BMC Cancer       Date:  2012-07-19       Impact factor: 4.430

4.  The effect and mechanism of tamoxifen-induced hepatocyte steatosis in vitro.

Authors:  Fei Zhao; Ping Xie; Jiali Jiang; Lingqiang Zhang; Wei An; Yutao Zhan
Journal:  Int J Mol Sci       Date:  2014-03-05       Impact factor: 5.923

5.  Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk.

Authors:  C H Ahern; Y-C T Shih; W Dong; G Parmigiani; Y Shen
Journal:  Br J Cancer       Date:  2014-08-19       Impact factor: 7.640

6.  Awareness of breast cancer risk related to a positive family history and alcohol consumption among women aged 15-44 years in United States.

Authors:  Jaya S Khushalani; Jin Qin; Donatus U Ekwueme; Arica White
Journal:  Prev Med Rep       Date:  2019-12-09

7.  Breast Cancer Screening in Malaysia: A Policy Review.

Authors:  Mila Nu Nu Htay; Michael Donnelly; Desiree Schliemann; Siew Yim Loh; Maznah Dahlui; Saunthari Somasundaram; Nor Saleha Binti Ibrahim Tamin; Tin Tin Su
Journal:  Asian Pac J Cancer Prev       Date:  2021-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.